FDA NDC Directory · JSON-LD · Markdown

COSENTYX

NDC 0078-1168 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION, CONCENTRATE

Generic namesecukinumab
Labeler / ManufacturerNovartis Pharmaceuticals Corporation
Marketing categoryBiologic License Application · App BLA761349
Dosage form / routeINJECTION, SOLUTION, CONCENTRATE · INTRAVENOUS
Active ingredientsSECUKINUMAB (25 mg/mL)
Marketing started20231006
Package count1

External sources

Source: openFDA. Public-domain (CC0).